Related content

Induction chemotherapy with cetuximab, carboplatin and paclitaxel for the treatment of locally advanced squamous cell carcinoma of the head and neck

By                

Experimental and Therapeutic Medicine, Vol. 5, Iss. 4, 2013-01 ,pp. : 1247-1253

Spandidos Publications

Access to resources Recommend Favorite

Nab‐paclitaxel‐based compared to docetaxel‐based induction chemotherapy regimens for locally advanced squamous cell carcinoma of the head and neck

By  

Cancer Medicine, Vol. 4, Iss. 4, 2015-04 ,pp. : 481-489

John Wiley & Sons Inc

Access to resources Recommend Favorite

PLU-1/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma

By                

Oncology Reports, Vol. 33, Iss. 5, 2015-01 ,pp. : 2454-2460

Spandidos Publications

Access to resources Recommend Favorite

p53 mutation and cyclin D1 amplification correlate with cisplatin sensitivity in xenografted human squamous cell carcinomas from head and neck

By Henriksson Eva   Baldetorp Bo   Borg Åke   Kjellen Elisabeth   Åkervall Jan   Wennerberg Johan   Wahlberg Peter  

Acta Oncologica, Vol. 45, Iss. 3, 2006-04 ,pp. : 300-305

Informa Healthcare

Access to resources Recommend Favorite

Early evaluation of neoadjuvant chemotherapy response using FDG-PET/CT predicts survival prognosis in patients with head and neck squamous cell carcinoma

By Kikuchi Masahiro  

International Journal of Clinical Oncology, Vol. 18, Iss. 3, 2013-06 ,pp. : 402-410

Springer Publishing Company

Access to resources Recommend Favorite